Lv71
4180 积分 2024-07-26 加入
Key breakthroughs in small molecule MYC inhibitors
1个月前
已完结
Emerging Insights into the PI3K/AKT/mTOR Signaling Pathway and Non-Coding RNA-mediated Drug Resistance in Glioblastoma
1个月前
已完结
Pre-empting drug resistance
1个月前
已完结
Targeting the Hippo pathway in cancer
2个月前
已完结
Stress it up
3个月前
已完结
Akt Inhibitor Advancements: From Capivasertib Approval to Covalent-Allosteric Promises
3个月前
已完结
Delivering on the promise of protein degraders
5个月前
已完结
Molecular glue degraders: exciting opportunities for novel drug discovery
5个月前
已完结
The European Federation for Medicinal Chemistry and Chemical Biology (EFMC) Best Practice Initiative: Hit to Lead
5个月前
已完结
MYC in cancer: from undruggable target to clinical trials
5个月前
已完结
皖公网安备34019202002308
